HOME >> BIOLOGY >> NEWS
Nanotech safety needs specific government risk research strategy and funding

WASHINGTON--"Prioritizing nanotechnology risk research isn't rocket science," said Project on Emerging Nanotechnologies chief scientist Andrew Maynard. Dr. Maynard's remark is in his testimony today before the federal government's first public meeting focused exclusively on research needs and priorities for the environmental, health and safety risks of engineered nanoscale materials.

"The specific health and safety questions that are important to be addressed for nanotechnology are reasonably straightforward," according to Maynard. "And a lot already has been published about what we know and do not know about the potential risks and about how to fill existing research gaps."

"Far harder is getting the federal government to take action in three critical areas: first, documenting what relevant risk research exists; second, ensuring that agencies responsible for oversight and related research--the Environmental Protection Agency (EPA), Food & Drug Administration (FDA), National Institute of Environmental Health Sciences (NIEHS), National Institute for Occupational Safety & Health (NIOSH), the Consumer Product Safety Commission (CPSC)--are adequately funded; and third, developing a robust, top-down research plan that can be implemented by the U.S. government and used for collaborations with industry and with researchers in other countries," said Maynard.

During his presentation Maynard mixed a powdered nano calcium and magnesium dietary supplement into a glass of water to help illustrate key risk research questions the federal government needs to tackle: what effect do airborne nanoparticles have on the lungs, do nanoparticles penetrate the skin, what happens to nanoparticles in water, how do they behave in the gastrointestinal tract, and what happens to nanoparticles when they are poured down a drain and enter the waste stream?

Maynard points out that these are "obvious questions" but "ones that should be considered when priorit
'"/>

Contact: Lauren Crowley
lauren.crowley@wilsoncenter.org
202-691-4231
Project on Emerging Nanotechnologies
4-Jan-2007


Page: 1 2

Related biology news :

1. Nanotechnology helps scientists make bendy sensors for hydrogen vehicles
2. FDA Nanotechnology Task Force takes positive step forward
3. A new report, Where Does the Nano Go? End-of-Life Regulation of Nanotechnologies
4. Nanotech hitchhikers in blood
5. Nanotechnology, medicine and bioethics
6. Nanotechnology: consumers must be convinced benefits outweigh risks
7. Nanotechnology requires immediate changes in EPA
8. Nanotechnology provides green path to environmentally sustainable economy
9. Nanotechnology offers hope for treating spinal cord injuries, diabetes and Parkinsons disease
10. Green Nanotechnology: Its Easier Than You Think
11. Nanotechnologys past, present and future: A Congressional perspective

Post Your Comments:
(Date:5/19/2013)... study reports that white men and women of European ... valgus) and lesser toe deformities, including hammer or claw ... estimate the heritability of foot disorders in humansappear in ... by Wiley on behalf of the American College of ... many as 60% of older adults have foot disorders ...
(Date:5/18/2013)... today at Digestive Disease Week (DDW) explores new discoveries ... of coffee on autoimmune disease and palliative care for ... been associated with reduced risk of fibrosis, a new ... java each month also correlate with lower risk for ... Clinic, Rochester, MN, linked coffee consumption with reduced risk ...
(Date:5/17/2013)... South, but the night belongs to the amphibians. In ... humidity and the sounds of wildlife. , The Southeast, ... salamanders, is the center of amphibian biodiversity in our nation. ... their symphonic choruses, the scientists of the U.S. Geological Survey,s ... , Amphibians, which rely on water for part ...
Breaking Biology News(10 mins):Blame your parents for bunion woes 2Coffee consumption associated with reduced risk of autoimmune liver disease 2Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
(Date:5/20/2013)... Biomarkers and Clinigene International are set to unveil their ... 2013 AAPS/ National Biotechnology Conference May 20-22 ... Marina , San Diego, CA. ... company representatives at their collaborative seminar, "Biosimilarity, Immunogenicity and ... 1-2 p.m. in the conference,s Spinnaker Room. ...
(Date:5/20/2013)... HILL, N.C. , May 20, 2013 /PRNewswire/ ... company focused on developing differentiated antibiotics to meet ... infections, today announced that it presented data at ... in Philadelphia demonstrating the ... levofloxacin in Cempra,s prior Phase 2 clinical trial ...
(Date:5/20/2013)... Interventional cardiologist Tony Farah, MD, and his ... Cardiovascular Institute have helped pioneer many breakthroughs in ... over the past three decades, from new disease-fighting medications ... artery stent implantation. , Today, AGH officials announced that ... in the study of a novel, first-of-its kind investigational ...
(Date:5/20/2013)... 2013 On 25-28 July, 2013, UPCP ... Paris - the beautiful city of lights. , According ... is revolutionizing the medical world. Understanding and integrating genetic ... hallmark of this transformation. Much of the present medical ... epidemiologic studies of large cohorts that do not take ...
Breaking Biology Technology:Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris 2
Cached News: